- occupational skin diseases (OSD) represent up to 30% of occupational diseases
- OSD related costs exceed 5 billion €/year by loss of productivity
- there are isolated efforts of OSD prevention in some countries
- there is no coordinated action between the stakeholders at national and international levels
- surveillance and diagnostics of OSD are hampered by lack of common monitoring of new allergens in workplaces.
The EU Commission therefore defined lacking prevention of OSD a top priority problem.
"StanDerm" comprises 31 countries and aims at coordinating activities relevant for OSD prevention, including basic sciences (aetiology and individual susceptibility), epidemiological surveillance, transnational and applied clinical research.This involves regulatory issues (e.g. REACH), development of interdisciplinary workers' education concepts, identifying individual susceptibility markers enabling tailored prevention and pre-employment counselling.
This COST Action will allow setting up transnational controlled intervention studies in large cohorts in high-risk professions. The outcome will be evidence-based common European standards on OSD prevention and patient management. This will provide a safer working environment and targeted early intervention for workers throughout Europe, enhancing economic competitiveness, particularly of small and medium-sized enterprises (SMEs).
A Memorandum of Unterstanding (MoU) is signed by the participating governments of the COST countries. The MoU details the content, the arrangement and related activities for the implementation of the Action.